{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:04:11Z","timestamp":1765807451055},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Bundesministerium f\u00fcr Bildung und Forschung (DE)","award":["BMBF 01 EO 0803"],"award-info":[{"award-number":["BMBF 01 EO 0803"]}]},{"name":"Seventh Framework Programme (BE)","award":["223293"],"award-info":[{"award-number":["223293"]}]},{"name":"Seventh Framework Programme (BE)","award":["EURO-PADnet HEALTH-F2-2008-201549"],"award-info":[{"award-number":["EURO-PADnet HEALTH-F2-2008-201549"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12865-017-0217-9","type":"journal-article","created":{"date-parts":[[2017,6,26]],"date-time":"2017-06-26T07:27:42Z","timestamp":1498462062000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Autoantibodies against BAFF, APRIL or IL21 - an alternative pathogenesis for antibody-deficiencies?"],"prefix":"10.1186","volume":"18","author":[{"given":"Marian-Christopher","family":"Pott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Frede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Wanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lennart","family":"Hammarstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik-Oliver","family":"Glocker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Glocker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fariba","family":"Tahami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bodo","family":"Grimbacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,26]]},"reference":[{"key":"217_CR1","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1086\/514141","volume":"176","author":"JE Tanner","year":"1997","unstructured":"Tanner JE, Diaz-Mitoma F, Rooney CM, Alfieri C. Anti-interleukin-10 antibodies in patients with chronic active Epstein-Barr virus infection. J Infect Dis. 1997;176:1454\u201361.","journal-title":"J Infect Dis"},{"key":"217_CR2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0167-5699(90)90068-K","volume":"11","author":"K Bendtzen","year":"1990","unstructured":"Bendtzen K, Svenson M, Jonsson V, Hippe E. Autoantibodies to cytokines--friends or foes? Immunol Today. 1990;11:167\u20139.","journal-title":"Immunol Today"},{"key":"217_CR3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.copbio.2009.10.007","volume":"20","author":"M Sauerborn","year":"2009","unstructured":"Sauerborn M, Schellekens H. B-1 cells and naturally occurring antibodies: influencing the immunogenicity of recombinant human therapeutic proteins? Curr Opin Biotechnol. 2009;20:715\u201321.","journal-title":"Curr Opin Biotechnol"},{"key":"217_CR4","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.190.6.875","volume":"190","author":"T Kitamura","year":"1999","unstructured":"Kitamura T, Tanaka N, Watanabe J, Uchida, Kanegasaki S, Yamada Y, Nakata K. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte\/macrophage colony-stimulating factor. J Exp Med. 1999;190:875\u201380.","journal-title":"J Exp Med"},{"key":"217_CR5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJMoa011931","volume":"346","author":"N Casadevall","year":"2002","unstructured":"Casadevall N, Nataf J, Viron B, Kolta A, Kiladjian J, Martin-Dupont P, Michaud P, Papo T, Ugo V, Teyssandier I, Varet B, Mayeux P. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med. 2002;346:469\u201375.","journal-title":"N Engl J Med"},{"key":"217_CR6","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1056\/NEJMoa074037","volume":"361","author":"IC Macdougall","year":"2009","unstructured":"Macdougall IC, Rossert J, Casadevall N, Stead RB, Duliege A, Froissart M, Eckardt K. A peptide-based erythropoietin-receptor agonist for pure red-cell aplasia. N Engl J Med. 2009;361:1848\u201355.","journal-title":"N Engl J Med"},{"key":"217_CR7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1084\/jem.20091983","volume":"207","author":"A Puel","year":"2010","unstructured":"Puel A, Doffinger R, Natividad A, Chrabieh M, Barcenas-Morales G, Picard C, Cobat A, Ouachee-Chardin M, Toulon A, Bustamante J, Al-Muhsen S, Al-Owain M, Arkwright PD, Costigan C, McConnell V, Cant AJ, Abinun M, Polak M, Bougneres P, Kumararatne D, Marodi L, Nahum A, Roifman C, Blanche S, Fischer A, Bodemer C, Abel L, Lilic D, Casanova J. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med. 2010;207:291\u20137.","journal-title":"J Exp Med"},{"key":"217_CR8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20091669","volume":"207","author":"K Kisand","year":"2010","unstructured":"Kisand K, B\u00f8e W, Anette S, Podkrajsek KT, Tserel L, Link M, Kisand KV, Ersvaer E, Perheentupa J, Erichsen MM, Bratanic N, Meloni A, Cetani F, Perniola R, Ergun-Longmire B, Maclaren N, Krohn, Kai JE, Pura M, Schalke B, Str\u00f6bel P, Leite MI, Battelino T, Husebye ES, Peterson P, Willcox N, Meager A. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med. 2010;207:299\u2013308.","journal-title":"J Exp Med"},{"key":"217_CR9","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1371\/journal.pmed.0030289","volume":"3","author":"A Meager","year":"2006","unstructured":"Meager A, Visvalingam K, Peterson P, M\u00f6ll K, Murum\u00e4gi A, Krohn K, Eskelin P, Perheentupa J, Husebye E, Kadota Y, Willcox N. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med. 2006;3:e289.","journal-title":"PLoS Med"},{"key":"217_CR10","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4049\/jimmunol.180.1.647","volume":"180","author":"A Puel","year":"2008","unstructured":"Puel A, Picard C, Lorrot M, Pons C, Chrabieh M, Lorenzo L, Mamani-Matsuda M, Jouanguy E, Gendrel D, Casanova J. Recurrent staphylococcal cellulitis and subcutaneous abscesses in a child with autoantibodies against IL-6. J Immunol. 2008;180:647\u201354.","journal-title":"J Immunol"},{"key":"217_CR11","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1172\/JCI19316","volume":"115","author":"B Kampmann","year":"2005","unstructured":"Kampmann B, Hemingway C, Stephens A, Davidson R, Goodsall A, Anderson S, Nicol M, Sch\u00f6lvinck E, Relman D, Waddell S, Langford P, Sheehan B, Semple L, Wilkinson KA, Wilkinson RJ, Ress S, Hibberd M, Levin M. Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma. J Clin Invest. 2005;115:2480\u20138.","journal-title":"J Clin Invest"},{"key":"217_CR12","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1182\/blood-2013-01-474213","volume":"121","author":"A Puel","year":"2013","unstructured":"Puel A, Casanova J. Autoantibodies against cytokines: back to human genetics. Blood. 2013;121:1246\u20137.","journal-title":"Blood"},{"key":"217_CR13","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/MOH.0b013e328338f69e","volume":"17","author":"PM Wood","year":"2010","unstructured":"Wood PM. Primary antibody deficiency syndromes. Curr Opin Hematol. 2010;17:356\u201361.","journal-title":"Curr Opin Hematol"},{"key":"217_CR14","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.coi.2013.06.003","volume":"25","author":"K Liadaki","year":"2013","unstructured":"Liadaki K, Sun J, Hammarstr\u00f6m L, Pan-Hammarstr\u00f6m Q. New facets of antibody deficiencies. Curr Opin Immunol. 2013;25:629\u201338.","journal-title":"Curr Opin Immunol"},{"key":"217_CR15","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s10875-006-9026-2","volume":"26","author":"CG Losi","year":"2006","unstructured":"Losi CG, Salzer U, Gatta R, Lougaris V, Cattaneo G, Meini A, Soresina A, Grimbacher B, Plebani A. Mutational analysis of human BLyS in patients with common variable immunodeficiency. J Clin Immunol. 2006;26:396\u20139.","journal-title":"J Clin Immunol"},{"key":"217_CR16","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s10875-005-5637-2","volume":"25","author":"CG Losi","year":"2005","unstructured":"Losi CG, Silini A, Fiorini C, Soresina A, Meini A, Ferrari S, Notarangelo LD, Lougaris V, Plebani A. Mutational analysis of human BAFF receptor TNFRSF13C (BAFF-R) in patients with common variable immunodeficiency. J Clin Immunol. 2005;25:496\u2013502.","journal-title":"J Clin Immunol"},{"key":"217_CR17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/ni902","volume":"4","author":"B Grimbacher","year":"2003","unstructured":"Grimbacher B, Hutloff A, Schlesier M, Glocker E, Warnatz K, Dr\u00e4ger R, Eibel H, Fischer B, Sch\u00e4ffer AA, Mages HW, Kroczek RA, Peter HH. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol. 2003;4:261\u20138.","journal-title":"Nat Immunol"},{"key":"217_CR18","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ajhg.2012.04.015","volume":"90","author":"G Lopez-Herrera","year":"2012","unstructured":"Lopez-Herrera G, Tampella G, Pan-Hammarstr\u00f6m Q, Herholz P, Trujillo-Vargas CM, Phadwal K, Simon AK, Moutschen M, Etzioni A, Mory A, Srugo I, Melamed D, Hultenby K, Liu C, Baronio M, Vitali M, Philippet P, Dideberg V, Aghamohammadi A, Rezaei N, Enright V, Du L, Salzer U, Eibel H, Pfeifer D, Veelken H, Stauss H, Lougaris V, Plebani A, Gertz EM, et al. Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am J Hum Genet. 2012;90:986\u20131001.","journal-title":"Am J Hum Genet"},{"key":"217_CR19","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMoa051568","volume":"354","author":"C Zelm Menno van","year":"2006","unstructured":"van Zelm Menno C, Reisli I, van der Burg M, van Noesel CD, van Tol CJM, Maarten JD, Woellner C, Grimbacher B, Pati\u00f1o PJ, van Dongen Jacques JM, Franco JL. An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med. 2006;354:1901\u201312.","journal-title":"N Engl J Med"},{"key":"217_CR20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","volume":"92","author":"C Cunningham-Rundles","year":"1999","unstructured":"Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol (Orlando, Fla). 1999;92:34\u201348.","journal-title":"Clin Immunol (Orlando, Fla)"},{"key":"217_CR21","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/ACI.0b013e3283594219","volume":"12","author":"N Wang","year":"2012","unstructured":"Wang N, Hammarstr\u00f6m L. IgA deficiency: what is new? Curr Opin Allergy Clin Immunol. 2012;12:602\u20138.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"217_CR22","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.4049\/jimmunol.170.5.2765","volume":"170","author":"J Kralovicova","year":"2003","unstructured":"Kralovicova J, Hammarstr\u00f6m L, Plebani A, Webster A, David B, Vorechovsky I. Fine-scale mapping at IGAD1 and genome-wide genetic linkage analysis implicate HLA-DQ\/DR as a major susceptibility locus in selective IgA deficiency and common variable immunodeficiency. J Immunol (Baltimore, Md: 1950). 2003;170:2765\u201375.","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"217_CR23","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ng.644","volume":"42","author":"RC Ferreira","year":"2010","unstructured":"Ferreira RC, Pan-Hammarstr\u00f6m Q, Graham RR, Gateva V, Font\u00e1n G, Lee AT, Ortmann W, Urcelay E, Fern\u00e1ndez-Arquero M, N\u00fa\u00f1ez C, Jorgensen G, Ludviksson BR, Koskinen S, Haimila K, Clark HF, Klareskog L, Gregersen PK, Behrens TW, Hammarstr\u00f6m L. Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency. Nat Genet. 2010;42:777\u201380.","journal-title":"Nat Genet"},{"key":"217_CR24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.autrev.2006.03.010","volume":"5","author":"D Brandt","year":"2006","unstructured":"Brandt D, Gershwin ME. Common variable immune deficiency and autoimmunity. Autoimmun Rev. 2006;5:465\u201370.","journal-title":"Autoimmun Rev"},{"key":"217_CR25","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","volume":"134","author":"B Gathmann","year":"2014","unstructured":"Gathmann B, Mahlaoui N, G\u00e9rard L, Oksenhendler E, Warnatz K, Schulze I, Kindle G, Kuijpers TW, van Beem Rachel T, Guzman D, Workman S, Soler-Palac\u00edn P, de Gracia J, Witte T, Schmidt RE, Litzman J, Hlavackova E, Thon V, Borte M, Borte S, Kumararatne D, Feighery C, Longhurst H, Helbert M, Szaflarska A, Sediva A, Belohradsky BH, Jones A, Baumann U, Meyts I, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014;134:116\u201326.","journal-title":"J Allergy Clin Immunol"},{"key":"217_CR26","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.immuni.2008.02.010","volume":"28","author":"MP Cancro","year":"2008","unstructured":"Cancro MP. Living in context with the survival factor BAFF. Immunity. 2008;28:300\u20131.","journal-title":"Immunity"},{"key":"217_CR27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.coi.2007.04.008","volume":"19","author":"F Mackay","year":"2007","unstructured":"Mackay F, Silveira P, Brink R. B cells and the BAFF\/APRIL axis: fast-forward on autoimmunity and signaling. Curr Opin Immunol. 2007;19:327\u201336.","journal-title":"Curr Opin Immunol"},{"key":"217_CR28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2249.2009.04007.x","volume":"158","author":"I Moisini","year":"2009","unstructured":"Moisini I, Davidson A. BAFF: a local and systemic target in autoimmune diseases. Clin Exp Immunol. 2009;158:155\u201363.","journal-title":"Clin Exp Immunol"},{"key":"217_CR29","doi-asserted-by":"crossref","first-page":"497","DOI":"10.4049\/jimmunol.1102321","volume":"188","author":"M Kreuzaler","year":"2012","unstructured":"Kreuzaler M, Rauch M, Salzer U, Birmelin J, Rizzi M, Grimbacher B, Plebani A, Lougaris V, Quinti I, Thon V, Litzman J, Schlesier M, Warnatz K, Thiel J, Rolink AG, Eibel H. Soluble BAFF levels inversely correlate with peripheral B cell numbers and the expression of BAFF receptors. J Immunol (Baltimore, Md: 1950). 2012;188:497\u2013503.","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"key":"217_CR30","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.clim.2007.04.012","volume":"124","author":"AK Knight","year":"2007","unstructured":"Knight AK, Radigan L, Marron T, Langs A, Zhang L, Cunningham-Rundles C. High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency. Clin Immunol. 2007;124:182\u20139.","journal-title":"Clin Immunol"},{"key":"217_CR31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/35040504","volume":"408","author":"J Parrish-Novak","year":"2000","unstructured":"Parrish-Novak J, Dillon SR, Nelson A, Hammond A, Sprecher C, Gross JA, Johnston J, Madden K, Xu W, West J, Schrader S, Burkhead S, Heipel M, Brandt C, Kuijper JL, Kramer J, Conklin D, Presnell SR, Berry J, Shiota F, Bort S, Hambly K, Mudri S, Clegg C, Moore M, Grant FJ, Lofton-Day C, Gilbert T, Rayond F, Ching A, et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature. 2000;408:57\u201363.","journal-title":"Nature"},{"key":"217_CR32","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1600-065X.2008.00631.x","volume":"223","author":"R Ettinger","year":"2008","unstructured":"Ettinger R, Kuchen S, Lipsky PE. The role of IL-21 in regulating B-cell function in health and disease. Immunol Rev. 2008;223:60\u201386.","journal-title":"Immunol Rev"},{"key":"217_CR33","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1182\/blood-2009-02-207423","volume":"114","author":"S Borte","year":"2009","unstructured":"Borte S, Pan-Hammarstr\u00f6m Q, Liu C, Sack U, Borte M, Wagner U, Graf D, Hammarstr\u00f6m L. Interleukin-21 restores immunoglobulin production ex vivo in patients with common variable immunodeficiency and selective IgA deficiency. Blood. 2009;114:4089\u201398.","journal-title":"Blood"},{"key":"217_CR34","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nri1714","volume":"5","author":"CG Vinuesa","year":"2005","unstructured":"Vinuesa CG, Tangye SG, Moser B, Mackay CR. Follicular B helper T cells in antibody responses and autoimmunity. Nat Rev Immunol. 2005;5:853\u201365.","journal-title":"Nat Rev Immunol"},{"key":"217_CR35","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.1077002","volume":"298","author":"K Ozaki","year":"2002","unstructured":"Ozaki K. A critical role for IL-21 in regulating immunoglobulin production. Science. 2002;298:1630\u20134.","journal-title":"Science"},{"key":"217_CR36","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/stem.5530130303","volume":"13","author":"K Bendtzen","year":"1995","unstructured":"Bendtzen K, Hansen MB, Ross C, Poulsen LK, Svenson M. Cytokines and autoantibodies to cytokines. Stem Cells. 1995;13:206\u201322.","journal-title":"Stem Cells"},{"key":"217_CR37","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nri844","volume":"2","author":"F Mackay","year":"2002","unstructured":"Mackay F, Browning JL. BAFF: a fundamental survival factor for B cells. Nat Rev Immunol. 2002;2:465\u201375.","journal-title":"Nat Rev Immunol"},{"key":"217_CR38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejr.2010.12.001","volume":"33","author":"SM Fawzy","year":"2011","unstructured":"Fawzy SM, Gheita TA, El-Nabarawy E, El-Demellawy HH, Shaker OG. Serum BAFF level and its correlations with various disease parameters in patients with systemic sclerosis and systemic lupus erythematosus. Egypt Rheumatologist. 2011;33:45\u201351.","journal-title":"Egypt Rheumatologist"},{"key":"217_CR39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","volume":"111","author":"C Wehr","year":"2008","unstructured":"Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, Vlkova M, Hernandez M, Detkova D, Bos PR, Poerksen G, von Bernuth H, Baumann U, Goldacker S, Gutenberger S, Schlesier M, der Cruyssen Florence B-v, Le Garff M, Debr\u00e9 P, Jacobs R, Jones J, Bateman E, Litzman J, van Hagen PM, Plebani A, Schmidt RE, Thon V, Quinti I, Espanol T, Webster AD, et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood. 2008;111:77\u201385.","journal-title":"Blood"},{"key":"217_CR40","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1084\/jem.192.1.129","volume":"192","author":"JS Thompson","year":"2000","unstructured":"Thompson JS, Schneider P, Kalled SL, Wang L, Lefevre EA, Cachero TG, MACKAY F, Bixler SA, Zafari M, Liu ZY, Woodcock SA, Qian F, Batten M, Madry C, Richard Y, Benjamin CD, Browning JL, Tsapis A, Tschopp J, Ambrose C. BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population. J Exp Med. 2000;192:129\u201335.","journal-title":"J Exp Med"},{"key":"217_CR41","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1074-7613(01)00183-2","volume":"15","author":"JA Gross","year":"2001","unstructured":"Gross JA, Dillon SR, Mudri S, Johnston J, Littau A, Roque R, Rixon M, Schou O, Foley KP, Haugen H, McMillen S, Waggie K, Schreckhise RW, Shoemaker K, Vu T, Moore M, Grossman A, Clegg CH. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS. Immunity. 2001;15:289\u2013302.","journal-title":"Immunity"},{"key":"217_CR42","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1126\/science.1061964","volume":"293","author":"B Schiemann","year":"2001","unstructured":"Schiemann B, Gommerman JL, Vora K, Cachero TG, Shulga-Morskaya S, Dobles M, Frew E, Scott ML. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science. 2001;293:2111\u20134.","journal-title":"Science"},{"key":"217_CR43","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1126\/science.1061965","volume":"293","author":"JS Thompson","year":"2001","unstructured":"Thompson JS, Bixler SA, Qian F, Vora K, Scott ML, Cachero TG, Hession C, Schneider P, Sizing ID, Mullen C, Strauch K, Zafari M, Benjamin CD, Tschopp J, Browning JL, Ambrose C. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science. 2001;293:2108\u201311.","journal-title":"Science"},{"key":"217_CR44","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/cyto.b.20432","volume":"74B","author":"K Warnatz","year":"2008","unstructured":"Warnatz K, Schlesier M. Flowcytometric phenotyping of common variable immunodeficiency. Cytometry. 2008;74B:261\u201371.","journal-title":"Cytometry"},{"key":"217_CR45","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1084\/jem.192.10.1453","volume":"192","author":"M Batten","year":"2000","unstructured":"Batten M, Groom J, Cachero TG, Qian F, Schneider P, Tschopp J, Browning JL, MACKAY F. BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med. 2000;192:1453\u201366.","journal-title":"J Exp Med"},{"key":"217_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-3083.2010.02470.x","volume":"73","author":"GA Lied","year":"2011","unstructured":"Lied GA, Berstad A. Functional and clinical aspects of the B-cell-activating factor (BAFF): a narrative review. Scand J Immunol. 2011;73:1\u20137.","journal-title":"Scand J Immunol"},{"key":"217_CR47","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cytogfr.2013.04.003","volume":"24","author":"FB Vincent","year":"2013","unstructured":"Vincent FB, Saulep-Easton D, Figgett WA, Fairfax KA, Mackay F. The BAFF\/APRIL system: emerging functions beyond B cell biology and autoimmunity. Cytokine Growth Factor Rev. 2013;24:203\u201315.","journal-title":"Cytokine Growth Factor Rev"},{"key":"217_CR48","unstructured":"ESID - European Society for Immunodeficiencies: Diagnostic criteria for PID\/\/Clinical\/\/ESID - European Society for Immunodeficiencies. \nhttps:\/\/esid.org\/Working-Parties\/Registry\/Diagnosis-criteria\n\n. Accessed 20 Jan 2017."},{"key":"217_CR49","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2249.2007.03545.x","volume":"151","author":"A Gonzalez-Quintela","year":"2008","unstructured":"Gonzalez-Quintela A, Alende R, Gude F, Campos J, Rey J, Meijide LM, Fernandez-Merino C, Vidal C. Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clin Exp Immunol. 2008;151:42\u201350.","journal-title":"Clin Exp Immunol"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-017-0217-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,26]],"date-time":"2017-06-26T07:28:04Z","timestamp":1498462084000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-017-0217-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,26]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["217"],"URL":"https:\/\/doi.org\/10.1186\/s12865-017-0217-9","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,26]]},"article-number":"34"}}